Alteration of cholesterol biosynthetic pathways in the skin of mice administered polycyclic aromatic hydrocarbons

Cancer Res. 1988 May 1;48(9):2555-60.

Abstract

When polycyclic aromatic hydrocarbons were applied solely or together with a tumor promoter (12-O-tetradecanoylphorbol-13-acetate) to the skin of mice, a marked decrease in the level of lathosterol was observed, reflecting a significant change in the metabolism of sterols. Yet the total amount of cholesterol was not changed. When diazacholesterol (a metabolic inhibitor) was administered to mice, both desmosterol and 5 alpha-cholesta-7,24-dien-3 beta-ol accumulated in the skin, whereas the level of lathosterol decreased. These results seem to suggest that a significant portion of lathosterol is formed via 5 alpha-cholesta-7,24-dien-3 beta-ol in addition to the pathway through methostenol. When polycyclic aromatic hydrocarbon was applied to the skin of the mouse treated with diazacholesterol, a significant increase of desmosterol and a marked drop of the level of 5 alpha-cholesta-7,24-dien-3 beta-ol were observed. These results strongly suggest that polycyclic aromatic hydrocarbons perturb the metabolism of sterol in the skin of mice while keeping the total amount of cholesterol unchanged. A similar metabolism also seems to be operating in tumor tissue itself.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Azacosterol / pharmacology
  • Carcinogens / pharmacology*
  • Cholesterol / biosynthesis*
  • Male
  • Mass Spectrometry
  • Methylcholanthrene / pharmacology
  • Mice
  • Polycyclic Compounds / pharmacology*
  • Skin / drug effects*
  • Skin / metabolism
  • Skin Neoplasms / analysis
  • Sterols / analysis
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Carcinogens
  • Polycyclic Compounds
  • Sterols
  • Methylcholanthrene
  • Cholesterol
  • Azacosterol
  • Tetradecanoylphorbol Acetate